View web version

"The drug got approved, then [Dendreon] proved they could execute the logistics, then they secured Medicare reimbursement. Had you told me all three of those things would happen, I would have said, 'Here's your next blockbuster. Thousands of men are going to be treated with this.'"

Jim Caggiano


Pharma Report 2017: Keep Calm and Sell Drugs

Drug prices, as you may have heard, are kinda high. But price growth has slowed after sharp spikes in 2014 and 2015, leading analysts to believe that all the finger-wagging and payer pushback may be having an impact. In "The New New Normal," MM&M surveys the pharma scene, complete with in-depth looks at the top 12 drugmakers by U.S. sales.

CLICK HERE for additional content from the June 2017 issue of MM&M, including

Read the report. Share it instantly on Facebook, Twitter, and LinkedIn. Post your own comments. It's all FREE and it's right here.

For details on how to advertise in The Splash from MM&M, please email Doreen Gates

To unsubscribe from the The Splash from MM&M click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
275 7th Avenue, 10th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150

© 2017 Haymarket Media Inc.